Table 2

Patient characteristics

n (%)
Solid tumor patients25
 Male17 (68%)
 Female8 (32%)
 White, non-Hispanic21 (84%)
 Black, non-Hispanic2 (8%)
 Asian2 (8%)
Tumor type
 Prostate8 (32%)
 Bladder6 (24%)
 Breast4 (16%)
 Colon4 (16%)
 Ovarian1 (4%)
 Renal2 (8%)
Median age, yr (range)63 (42–81)
Median KPS80 (70–90)
Median no. of prior chemotherapies and biological therapies (range)5 (2–15)
Hematological tumor patients12
 Male7 (58%)
 Female5 (42%)
 White, Non-Hispanic11 (92%)
Tumor type
 Hodgkin’s lymphoma5 (42%)
 Non-Hodgkin’s lymphoma6 (50%)
 Multiple myeloma1 (8%)
Median age (range)39 (19–77)
Median KPS80 (70–90)
Median no. of prior chemotherapies and biological therapies (range)7 (4–15)
Stem cell transplants8 (67%)
 17 (58%)
 21 (8%)